Zoetis Inc. (NYSE: ZTS) is a large market cap stock with a market cap of 25896.93. It is in the Drugs – Generic industry and sector Healthcare, with a current P/E of 40.77, a forward P/E of 22.44 and EPS of 1.28. At a stock price of 52.18 (-0.25%) it has a dividend yield of 0.73%.
EPS growth for the last five years have been 29.30%, more recently this last year it has grown by -31.60%. The next year growth is going to be about 21.92% and more long-term 12.88% after five years. EPS growth quarter over quarter is 707.10%. Sales growth for the past five years have been 5.90% and sales growth quarter over quarter is 2.80%.
For performance, Zoetis Inc. the past week has seen a gain of 0.83%. For the last month performance for Zoetis Inc. is 1.74%. While the last quarter is 9.41% and half year, 10.81%. Finally for the year, performance is 27.11%.
The 52-week high for Zoetis Inc., is at -0.87%, and for the 52-week low it comes to a value of 36.95%. The 20-day simple moving average is 1.97% and 11.43% for the 200-day simple moving average.
Volatility for the week is at 1.66%, and for the month it is 1.43%. Zoetis Inc., has a target price of 54.92.
In terms of debt, long term debt/equity is 3.29, and for total debt/equity Zoetis Inc. has 3.29. The gross margin is 64.90%, while operating margin is 20.70%, the profit margin is 13.20%. The current ratio is 3.2 and the quick ratio is 1.7.
Insider ownership is at 0.01%, with instituitional ownership at 95.50%. Zoetis Inc. has a payout ratio of 35.10%. With the total shares outstanding coming to 496.3. The shares float is 494.52, with the float short at 1.54%, with short ratio coming to 2.36.
In terms of returns, the return on assets see Zoetis Inc., get 8.60%, with its returns on investment at 5.70%. Return on equity is 53.00%. So will the investors see the target price of 54.92, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.